Cargando…

CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma

BACKGROUND: The specificity and sensitivity of hepatocellular carcinoma (HCC) diagnostic markers are limited, hindering the early diagnosis and treatment of HCC patients. Therefore, improving prognostic biomarkers for patients with HCC is urgently needed. METHODS: HCC-related datasets were downloade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Qiliu, Huang, Hai, Zhu, Chunling, Hou, Qingqing, Wei, Shangmou, Xiao, Yi, Zhang, Zhi, Sun, Xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526619/ https://www.ncbi.nlm.nih.gov/pubmed/36193067 http://dx.doi.org/10.1155/2022/8421813

Ejemplares similares

Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis
por: Zhang, Xianfeng, et al.
Publicado: (2021)

ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma
por: Zhang, Qiaoling, et al.
Publicado: (2022)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
por: Zhou, Huifang, et al.
Publicado: (2019)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

Sialidase NEU1 May Serve as a Potential Biomarker of Proliferation, Migration and Prognosis in Melanoma
por: Peng, Qiu, et al.
Publicado: (2022)

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients
por: Zhu, Weiwei, et al.
Publicado: (2018)

Identification of key snoRNAs serves as biomarkers for hepatocellular carcinoma by bioinformatics methods
por: Xie, Qingqing, et al.
Publicado: (2022)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2017)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma
por: Lai, Xing, et al.
Publicado: (2022)

Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer
por: Xie, Yuan, et al.
Publicado: (2017)

Hsa_circ_0124554 may serve as a biomarker for the diagnosis of colorectal cancer: An observational study
por: Li, Kexin, et al.
Publicado: (2023)

Circular RNA hsa_circ_0007507 May Serve as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer
por: Zhang, Weiwei, et al.
Publicado: (2021)

Endogenous glucocorticoids may serve as biomarkers for migraine chronification
por: Woldeamanuel, Yohannes W., et al.
Publicado: (2020)

High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma
por: Wei, Yong-Guang, et al.
Publicado: (2022)

Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer
por: Zhu, Linyan, et al.
Publicado: (2018)

High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis
por: Deng, Huan, et al.
Publicado: (2021)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma
por: Li, Juanni, et al.
Publicado: (2022)

Genes associated with inflammation may serve as biomarkers for the diagnosis of coronary artery disease and ischaemic stroke
por: Zheng, Peng-Fei, et al.
Publicado: (2020)

CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Yang, Gang, et al.
Publicado: (2021)

CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
por: Wu, Wen-jing, et al.
Publicado: (2013)

Cancer stemness-associated LINC02475 serves as a novel biomarker for diagnosis and prognosis prediction of hepatocellular carcinoma
por: Lin, Xian, et al.
Publicado: (2022)

The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker
por: Zhang, Xianwei, et al.
Publicado: (2018)

Tre2-Bub2-Cdc16 Family Proteins Based Nomogram Serve as a Promising Prognosis Predicting Model for Melanoma
por: Tang, Ling, et al.
Publicado: (2020)

Doing the CDC20 shuffle
por: Wells, William A.
Publicado: (2003)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
por: Yang, Hai-deng, et al.
Publicado: (2023)

CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20
por: Li, Feng, et al.
Publicado: (2021)

Focal adhesion kinase is overexpressed in thymic epithelial tumors and may serve as an independent prognostic biomarker
por: Li, Meng, et al.
Publicado: (2018)

Identification of CDC20 as a Novel Biomarker in Diagnosis and Treatment of Wilms Tumor
por: Shi, Qinlin, et al.
Publicado: (2021)

Genes associated with inflammation and the cell cycle may serve as biomarkers for the diagnosis and prognosis of acute myocardial infarction in a Chinese population
por: Su, Jiang, et al.
Publicado: (2018)

SIRT2 expression exhibits potential to serve as a biomarker for disease surveillance and prognosis in the management of cervical cancer patients
por: Yang, Li-ping, et al.
Publicado: (2020)

LRRC59 serves as a novel biomarker for predicting the progression and prognosis of bladder cancer
por: Zhang, Peng, et al.
Publicado: (2023)

Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma
por: Han, Ke‐qi, et al.
Publicado: (2016)

Response to transarterial chemoembolization may serve as selection criteria for hepatocellular carcinoma liver transplantation
por: Lei, Jianyong, et al.
Publicado: (2017)

Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma
por: Tamai, Yasuyuki, et al.
Publicado: (2020)

SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
por: Yoo, Wonbeak, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8i5idq0ibbpv9ppato19etaqd2